IDS Ltd

Automation - The Alliance

An Alliance with a Future Focus Leaders in our respective fields, partners in automation.

IDS’ product pipeline is focused on expanding our automated bone and skeletal; growth factor portfolio, as well as entering the fields of cancer, renal and cardiac diagnostics.
New products will be complementary to those currently on offer, further reinforcing our position as a global leader in the bone disease and growth factor diagnostic markets.

Biocode has an excellent track record in Laboratory automation with more than 10,000 system placements to date.
The development company of the new system, Biocode, brings over 30 years automation experience to provide a unique, reliable next generation system. As of August 2007, Biocode Hycel is a wholly-owned subsidiary of IDS.

Technogenetics produce state-of-the-art infectious and autoimmune disease tests and again has over 30 years diagnostic experience. As a leader in their field, Technogenetics are looking to the future with the next generation analytes for infectious disease, rheumatoid arthritis, antiphospholipid syndrome and other autoimmune parameters.